Loading
CN
China NT Pharma Group Co. Ltd. Stock: price and insider trades · Hong Kong
HK·Mcap HK$539M
No insider purchase over the last 90 days. The latest, by Chin Yu, was filed 25 Feb 2025.
China NT Pharma Group Co. Ltd.: what insiders have been doing
Every trade that managers of China NT Pharma Group Co. Ltd. disclose to HKEX is tracked on this page. Nothing new has been filed by managers of China NT Pharma Group Co. Ltd. in twelve months, the latest record being from 25 February 2025.
Over the whole record (from 2017), the tally stands at 30 purchases and 9 sales.
For comparison within the same market, see the insider buying recorded at Sun Hung Kai Properties Ltd. and Xinyi Glass Holdings Ltd. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Insider Decl.
40
Thresholds
n/a
Buy Volume
€57M
30 ops. · all time
Sell Volume
€19M
9 ops. · all time
Who traded when
BuySaleChin Yu1 buy
Ng Tit1 buy
Since the insiders bought
- +276.8%Entry HK$0.21 · Close at T+365 HK$0.78
- +276.8%Entry HK$0.21 · Close at T+365 HK$0.78
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$0.30
Analyst consensus
Income statement
RevenueHK$24.2M
Gross profitHK$9.6M40% margin
EBITDAHK$2.2M9% margin
Net income-HK$26M-76.9% margin
Valuation
Beta-1.96
Balance sheet & cash
Market capHK$539M
Total debtHK$316.7M
Free Cash Flow-HK$5.5M
Profitability & ownership
ROA-1.8%
% insiders90.2%
% institutions0.0%
Last declaration on 25 February 2025
Declarations40 total
2,800,046 sharesShareXHKGHKEX:DA20201016E00041
25 of 40 declarations
About China NT Pharma Group Co. Ltd.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations